David Renzi is listed as an executive officer and director on 13 SEC Form D filings by 3 issuers between May 2009 and May 2020: NEOMEND INC (Irvine, CA — other health care — 2009–2011; $33.1M reported sold to 15 investors), MINERVA SURGICAL INC (Santa Clara, CA — other health care — 2016–2020; $26.2M reported sold to 26 investors) and Carbylan Therapeutics, Inc. (Palo Alto, CA — other health care — 2014–2015; $6M reported sold to 4 investors).
What this means A repeat sponsor — 3 separate companies raised money with this person listed as executive officer and director, over about 11 years. Across those companies the filings report $65.3M sold in total.
Listed alongside Albert Cha (13 shared filings), David Clapper (9 shared filings), Bruno Strul (6 shared filings), Rodney Perkins (6 shared filings), Ross Jaffe (6 shared filings) and 24 others.
What this means These are the other officers, directors or promoters the companies named on the same forms — the team around David. Each name links to their own page.
Public records searched: federal courts (CourtListener / RECAP), SEC enforcement releases, state securities regulators (AK, AL, AR, AZ, CA, CT, DE, FINRA, GA, HI, ID, IL, KS, KY, LA, MA, MD, ME, MI, MO, MS, MT, NASAA, NC, ND, NH, NM, NV, OK, OR, PA, RI, SC, SD, TN, TX, VT, WA, WI, WV, WY) — 1 bankruptcy case matching the name listed in Key records below.
What this means 1 record came back. Each one is listed below with a link to the original document and a line saying why it matched. A name match is not proof it is the same person or company — read the why line and the document. Being sued or named in a release is an accusation, not a finding.
We compared 13 public filings for David Renzi and found 12 differences, 3 worth asking the sponsor about: Bankruptcy case: David M. Renzi; Amount sold went down between filings; and more below.
What this means These are differences between the sponsor's own SEC filings — both values, dates and sources are listed in Key records, section 4. Most have ordinary explanations; ask the sponsor.